Transcend Therapeutics

This study followed 44 people with PTSD who had already completed a previous trial with the drug TSND-201 (methylone). Over 52 weeks, researchers checked their symptoms and safety each month. If symptoms returned, participants could get more treatment. The goal was to see if meth…

This study tested a drug called methylone in 62 adults with severe PTSD. Participants received the drug once a week for 3 to 4 weeks, then were followed for up to 8 weeks. The goal was to see if methylone safely reduces PTSD symptoms like flashbacks and anxiety. The trial is now …

This study tested whether methylone, a substance similar to MDMA, is safe and can help reduce PTSD symptoms. 79 adults with moderate to severe PTSD who had not improved with other treatments received either methylone or a placebo once a week for four weeks. Researchers measured c…

This study tested a single dose of methylone in 40 healthy adults aged 25 to 55. Researchers measured how much of the drug got into the blood and how long it stayed, and watched for side effects. The goal was to gather safety information, not to treat PTSD directly.